HOLDco

Samuel Edwards
  • 0.0 (0)
  • Entrepreneurship

Dynamic holding company podcast, covering varying topics on M&A, marketing, software engineering and deal strategies. We discuss topics and provide details of our various holdings at HOLD.co.

  1. 15h ago

    Why Bigger Isn't Always Better in Acquisitions

    Deal size can be one of the most seductive — and most dangerous — variables in an acquisition. This episode of HoldCo examines the hidden costs of chasing large targets and makes the case for a more disciplined approach: buying right-sized businesses that fit cleanly into your strategy, rather than impressive ones that just make the press release pop. The argument draws directly from the full HoldCo article on acquisition size discipline. Here's what the episode covers: Why scale seduces: Large revenue numbers and synergy projections create momentum in the room — but that momentum often obscures the real risks hiding in the deal. Integration friction at scale: Big deals tangle systems, vendors, and workflows in ways that can take years to unravel, leaving customers underserved and competitors circling. The management attention problem: Senior leaders absorbed in triage can't sharpen the product, brand, or funnel — and trading creative momentum for project management is a costly swap. Cultural drag: Larger combined organisations move more slowly, run fewer experiments, and lose the urgency that drives growth — a cost that never shows up in the model but gets paid in missed windows. The case for smaller targets: Simpler books, shorter payback periods, and genuine optionality — a portfolio of right-sized deals builds compounding learning that a single mega-deal simply can't replicate. How to execute with discipline: Define a single, narrow job for the acquisition, price only what you can control, keep the org structure lean, and build a repeatable playbook that improves with every deal. The episode closes with a practical framework for becoming the kind of buyer that attracts better opportunities over time — where clean processes, realistic promises, and consistent discipline create a compounding advantage that bold, headline-chasing deals rarely deliver. For more on the complexity that can come with certain deal types, listen to Why Financial Services M&A Is One of the Most Complex Deals You'll Ever Do. Hold VDR

  2. 1d ago

    Why Financial Services M&A Is One of the Most Complex Deals You'll Ever Do

    Selling a financial services business — whether it's a registered investment adviser, an insurance agency, a specialty lender, or a fintech platform — is fundamentally different from selling almost any other type of company. This episode of HoldCo draws on the deep-dive analysis on financial services M&A complexity to walk middle market founders through the hidden dynamics that shape valuations, deal structures, and whether a transaction closes at all. The episode covers the key forces that define financial services transactions and how prepared sellers can navigate each one: The asset is people and relationships. In RIA transactions and similar businesses, AUM figures drive headline valuations — but those assets belong to clients who can leave with minimal friction, making earnouts and rollover equity structural necessities rather than negotiating footnotes. Licensing and regulatory transfer can make or break timelines. Change-of-control triggers, FINRA notifications, state insurance department approvals, and OCC oversight can add months to a process — and those timelines are outside either party's control. Sector-specific valuation frameworks apply. Wealth management, insurance, and specialty finance businesses are each valued on different bases (AUM multiples, commission multiples, book value), and generalist buyers frequently underprice what a strategic or sector-focused acquirer will pay. Buyer selection requires real market intelligence. Strategic acquirers — roll-up RIAs, regional banks, insurance holding companies — often outbid financial buyers because of synergies a financial buyer can't access. Knowing who is actively acquiring in a specific subsector is not optional. Revenue quality is scrutinized closely. Recurring, fee-based revenue commands higher multiples than commission or transactional revenue, and any shift in revenue mix needs to be clearly documented so buyers can underwrite trajectory rather than snapshots. Compliance history surfaces in diligence — sellers control the narrative only if they surface issues proactively. Regulatory inquiries, customer complaints, or disciplinary history discovered mid-process by a buyer typically result in repricing, restructuring, or a dead deal. The episode closes with a clear takeaway: the sellers who achieve the best outcomes in financial services M&A are those who arrive at the process already understanding what they're selling, who the right buyers are, and what those buyers need to see to pay full value. More from the show: listen to Lender Package Prep: What the Bank Needs Before It Will Credit the Deal for a practical look at how to prepare financial materials that hold up under institutional scrutiny. Investment Bank VDR

  3. 2d ago

    Lender Package Prep: What the Bank Needs Before It Will Credit the Deal

    A signed deal with a blessed IC memo is not a done deal — not until the lender's credit committee signs off too. This episode of HoldCo examines the structural gap between the data room a deal team builds for an equity buyer and the package a bank needs to underwrite debt, and it lays out a practical framework for closing that gap before it becomes a fire drill. The conversation covers the three pillars of a lender-ready package and why each one demands deliberate preparation well before the bank sends its first formal request list: Financial model and EBITDA bridge: Lenders run deals downward, not upward — they need a stress-case toggle and covenant headroom analysis built into the model from the start, plus a standalone reconciliation from audited GAAP to adjusted LTM EBITDA that any analyst can locate in seconds inside the virtual data room. Legal structure summary: Entity tree, borrower/guarantor designations, existing liens, and intercompany loans are typically scattered across multiple folders; pulling them into a single collateral narrative — and ensuring lender counsel has the right access — prevents duplicative legal work and version-control chaos. Change-of-control consent tracker: If the deal team has already triaged material contracts for assignment restrictions and consent requirements, sharing that output proactively (with status updates) spares the lender from running the same exercise and arriving at a different answer. Tools built for change-of-control review make it easier to surface and document this work early. The credit memo as an argument, not a summary: The information memorandum or credit memo should make an affirmative case for debt serviceability — and every factual claim should include an explicit cross-reference to the supporting document's folder path in the data room, eliminating early-morning email chains and multi-day latency. Folder architecture from day one: Building a lender-ready folder structure alongside the equity-buyer structure — and using saved document sets or views to pre-define the lender package as a shareable collection — means assembly at the critical moment is a packaging exercise, not a new analysis. Granular permissions make it straightforward to expose exactly the right materials to lender counsel without restructuring the room. Timing is everything: The stress case, the EBITDA bridge, the legal summary, and the consent tracker should all be substantially complete by IC approval — the bank's first formal request list should confirm the package, not initiate it. For more context on structuring a diligence process that serves multiple downstream audiences, see the M&A due diligence guide and the virtual data room guide at VDR.ai. And for a different angle on deal structure and long-term planning, check out Sell, Defer, and Leave a Legacy: How CRTs Change the M&A Game from the HoldCo back catalogue. VDR

  4. 3d ago

    Sell, Defer, and Leave a Legacy: How CRTs Change the M&A Game

    For founders who've spent decades building a company, the tax bill that follows a successful exit can feel like a betrayal. Charitable Remainder Trusts — a sophisticated but underused planning tool — offer a way to reframe the entire liquidity event, turning a single taxable windfall into a structure that delivers deferred tax, steady income, and philanthropic impact simultaneously. This episode of HoldCo walks through the mechanics, the tradeoffs, and the deal-timing rules that determine whether a CRT works or falls apart. It's based on the in-depth M&A analysis of CRTs for business sellers published at Mergers & Acquisitions. Here's what the episode covers: How CRTs work at a structural level — why a tax-exempt trust executing the sale, rather than the founder directly, changes the entire capital gains calculus CRUTs vs. CRATs — the difference between a variable annual payout tied to portfolio performance and a fixed annuity-style income stream, and which tends to suit M&A sellers better The three stacking advantages — capital gains deferral, lifetime income conversion, and an immediate charitable deduction, all triggered by a single coordinated move at closing The critical timing rule — why shares must be transferred into the trust before any binding sale agreement is signed, and how experienced deal counsel can build that window into the transaction structure S-corp and LLC considerations — special shareholder eligibility rules that require early planning, and how entity-level debt complicates contributed interests Wealth-replacement strategies for heirs — how an irrevocable life insurance trust funded from CRT income can preserve or even enhance what passes to the next generation, even though the trust remainder goes to charity The episode also addresses two common objections head-on: the fear of losing control over assets once they're inside an irrevocable trust, and the assumption that CRTs are only viable for nine-figure exits. On both counts, the reality is more nuanced — and more accessible — than most founders expect. For more on deal structure and the financial metrics that drive M&A outcomes, check out the earlier HoldCo episode Why EBITDA Lies: PE's Favorite Financial Fairy Tale. Mergers & Acquisitions VDR

  5. 4d ago

    Why EBITDA Lies: PE's Favorite Financial Fairy Tale

    EBITDA dominates the language of deals, pitch decks, and lending decisions — but how much does it actually reveal about a company's financial health? This episode of HoldCo pulls apart the metric that private equity loves most, using the full article on why EBITDA distorts financial reality as its foundation. The result is a clear-eyed look at how a single number can be engineered to make debt-laden, cash-burning businesses appear robust — and why sophisticated investors have learned to look elsewhere. Here's what the episode covers: What EBITDA actually strips out — and why depreciation, amortization, and interest aren't accounting noise but genuine costs of staying in business. The leveraged buyout trap — how loading debt onto an acquired company's balance sheet becomes invisible in the headline EBITDA figure, masking real cash-flow pressure until it's too late. Adjusted EBITDA: the next level of distortion — how "one-time" charges that recur every quarter get quietly erased, producing a figure closer to marketing than analysis. The CapEx blind spot — why ignoring capital expenditure flatters capital-intensive businesses and sets them up for a reckoning when aging assets finally need replacing. WeWork as a cautionary tale — a real-world case study in the gap between EBITDA projections and cash-flow reality. What to measure instead — free cash flow, interest coverage, liquidity, and net income as the metrics that cut through the noise and reflect what a business actually earns. The episode's core argument is blunt: EBITDA is a useful starting point for rough cross-company comparisons, but using it as the primary basis for valuation or lending is an unacknowledged gamble. The incentive structures of private equity reward deal-making over long-term stewardship, and EBITDA thrives in that environment precisely because it tells the story everyone at the table wants to hear. When the debt eventually comes due and the cash flow fails to materialize, no amount of adjustments changes the outcome. For more on deal dynamics and how metrics get used to frame acquisitions, listen to Healthcare M&A in the Middle Market: What Founders Need to Know — another episode that examines the gap between how deals are presented and how they actually play out. Hold VDR

  6. 5d ago

    Healthcare M&A in the Middle Market: What Founders Need to Know

    Healthcare is one of the most active corners of middle-market M&A — and one of the least forgiving for unprepared sellers. This episode of HoldCo draws on the healthcare M&A research and deal insight from Investment Bank to walk founders, physician group owners, and investors through the distinct rules that govern healthcare transactions — from how sub-sector dynamics shape value to the regulatory landmines that can detonate a deal weeks before closing. Here's what the episode covers: Healthcare is not one market. Physician practice management, home health, behavioral health, health IT, dental support organizations, and veterinary platforms each carry their own reimbursement logic, regulatory exposure, and buyer universe — and valuation follows accordingly. Payor mix is a pricing signal. A Medicare-heavy home health agency and a direct-pay concierge platform can look similar on revenue but trade at very different multiples, because buyers price in reimbursement risk, audit exposure, and potential clawback liability. The MSO structure is not optional in PE-backed physician deals. Corporate practice of medicine restrictions in most states mean private equity cannot directly own a clinical entity — management services organization structures are how these deals get done, and getting them wrong creates post-close regulatory exposure. Regulatory due diligence is its own discipline. Stark Law, the Anti-Kickback Statute, HIPAA, state licensure, and certificate of need laws are all live issues in any healthcare transaction. Historic billing irregularities — even unintentional ones — can trigger escrow holdbacks, RWI carve-outs, or outright deal failure. The buyer universe is wider than most founders realize. Hospital systems, PE sponsors, family offices, and tech-enabled acquirers each bring a different thesis and integration expectation — knowing what a buyer actually wants shapes how you tell your story. Earnouts and RWI require careful negotiation. Earnouts are common where payor concentration or key-person risk exists, but the definitions inside them are frequently disputed. Representations and warranties insurance mitigates post-close risk but routinely excludes known regulatory exposures surfaced in diligence. The episode closes with a practical argument for pre-transaction preparation: founders who arrive with clean financials, an organized data room, and a completed compliance review generate more competitive processes — and avoid giving buyers a reason to re-trade on price. More from the show: listen to Change-of-Control Clauses: The Diligence Sweep That Kills Surprises at Closing for a closer look at how contract review shapes deal outcomes. Investment Bank VDR

  7. 6d ago

    Change-of-Control Clauses: The Diligence Sweep That Kills Surprises at Closing

    Change-of-control clauses don't announce themselves. They sit quietly in software licenses, lease agreements, and co-marketing deals — far from the revenue-generating contracts that get the most attention — until a lender's counsel finds one two weeks before closing and the counterparty realizes it has leverage. This episode of HoldCo walks through the discipline of surfacing that exposure early: not just the mechanics of a contract sweep, but the prioritization logic and documentation habits that turn diligence into a defensible, deal-ready workstream. Here's what the episode covers: Why scope is the first failure point: "Important" contracts aren't the only ones with teeth — change-of-control risk hides across contract types that most teams under-review. Building a complete contract inventory first: Every executed agreement in the data room gets logged before anyone reads for substance — counterparty, type, dates, and review status — so nothing falls through a misfiled subfolder. Triaging by termination impact, counterparty posture, and clause flavor: Not all consent requirements carry equal risk; the analysis turns on replaceability, relationship health, and exactly what the provision says. The four clause types that drive different workstreams: Notice-only obligations, consent-required with no standard, consent-required with a reasonableness standard, and assignment or novation requirements each demand a different response plan and timeline. How the sweep connects to deal documentation: An incomplete sweep means an incomplete disclosure schedule, an inaccurate rep, and post-closing exposure — plus a lender condition to funding that may not be satisfied. Why documentation of non-issues matters as much as findings: Logging "no triggering language found" for every reviewed contract creates the audit trail that answers closing-day questions with evidence, not memory. Teams using change-of-control review tooling can systematize this categorization at scale, and cross-document reconciliation helps ensure that what the contract says lines up with what the disclosure schedule reflects. The episode also explores how careful clause reading can reveal that a provision simply doesn't trigger on the deal structure at hand — a stock acquisition versus an asset sale, or a financial sponsor buyer versus a strategic — and why asking that question early can meaningfully shrink the consent workstream. For teams building out their process from the ground up, the M&A due diligence guide covers the broader framework within which a change-of-control sweep sits. For more on how deal terms affect transaction structure from the outset, the HoldCo episode Cash vs. Equity: How to Take the Right Deal Terms in Any Market is a natural companion listen. VDR

  8. Aug 22

    Cash vs. Equity: How to Take the Right Deal Terms in Any Market

    A headline valuation tells you almost nothing about what a deal will actually put in your pocket. This episode of HoldCo digs into one of the most consequential choices any seller or buyer faces at the negotiating table: whether to transact in cash, equity, or some blend of the two — and how that single structural decision shapes liquidity, taxes, governance, and long-term wealth. The discussion draws on this in-depth guide to deal-term strategy from the Mergers & Acquisitions research team. The episode covers the full trade-off landscape for both sides of a transaction, including: Why price is only half the story — how two identical valuations can produce dramatically different outcomes depending on deal structure. The real appeal of cash deals — certainty at close, cleaner exits, and why it remains the right answer for retiring founders, PE sponsors nearing end-of-fund, or sellers with limited confidence in the buyer's direction. When equity becomes an opportunity, not a concession — rollover equity, tax-deferred reorganizations, and how stock consideration can close a valuation gap that cash financing alone cannot bridge. The rise of hybrid structures — why most mid-market deals today blend 60–70% cash at close with meaningful rollover equity, and how that alignment of incentives benefits both buyer and seller. Negotiation principles that protect your position — stress-testing share price volatility with collars, modeling post-tax proceeds before signing, securing governance rights in private equity rollovers, and ensuring indemnification caps reflect the actual consideration mix. Liquidity planning for equity holders — registration rights, secondary sale windows, and why failing to negotiate exit timing upfront can leave sellers stuck holding illiquid stock well past their intended horizon. The episode closes with a reminder that deal terms are rarely binary or fixed — sellers who enter negotiations with defined priorities and the right advisory team around them consistently find room to engineer structures that convert a compelling headline into real, durable value. Also from the show: if you want to understand why the growth-capital path introduces its own set of structural dangers for founders, the episode Why Most Founders Should Fear (Not Chase) Venture Capital is essential listening. Mergers & Acquisitions VDR

See All (92)

About

Dynamic holding company podcast, covering varying topics on M&A, marketing, software engineering and deal strategies. We discuss topics and provide details of our various holdings at HOLD.co.

Information

  • Creator
    Samuel Edwards
  • Years Active
    2026
  • Episodes
    92
  • Rating
    Clean
  • Copyright
    © Copyright 2026, HOLDDOTCO, LLC
  • Show Website
    HOLDco